Articles On Monash IVF Group (ASX:MVF)

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

It's looking like this Tuesday will be another positive day for the Australian share market and most ASX All Ords shares. At the time of writing, the All Ordinaries Index (ASX: XAO) has risen by a healthy 0.4%, leaving the index at just ove...

  US markets opened in positive territory before Fed rates commentary and a pop in oil prices spooked traders and triggered an afternoon sell off. The Dow Jones finished the day down 1.4 per cent, the S&P500 closed down 1.2 per cent aft...

The ASX 200 lifted modestly by +0.2% on Thursday as gains in Tech and Industrial stocks were offset by losses in Energy.  Local traders brushed out dovish comments from Fed Chair Jerome Powell last night. Appearing before Congress, Powell r...

  The S&P 500 rose Wednesday as investors attempted to turn a corner following back-to-back losing sessions on Wall Street. The S&P 500 added 0.51 per cent to 5,104.76, while the Nasdaq Composite gained 0.58 per cent to 16,031.54. T...

Note: Figures recorded at 7:40am AEDT. Updated figures and a video recording will be available at 9am AEDT. The S&P 500 rose Wednesday as investors attempted to turn a corner following back-to-back losing sessions on Wall Street. The br...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

QBE Insurance elevated to S&P/ASX 20 as gold miner Newmont removed Flight Centre and Pro Medicus both make the S&P/ASX 100 in March rebalance Several tech companies make benchmark S&P/ASX 200 but not so good for resources  Mar...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Today, Monday the 26th of February 2024, we are happy to buy Wagners (ASX:WGN), Bapcor Limited (ASX:BAP), Super Retail Group (ASX:SUL), Cedar Woods Properties (ASX:CWP), Accent Group (ASX:AX1), Avita Medical (ASX:AVH), Jumbo Interactive (AS...

ASX gains on Nvidia-fuelled rally AI adjacent stocks, such as data centre companies, also surge Afterpay parent Block Inc surges 17pc, Newmont crashes 7pc   The ASX 200 gained around 0.4% as the AI craze swept through global stock markets...

ASX health sector flat for week as broader market falls during volatile reporting season Avita Medical reports strong full year FY23 results, forecast to reach cashflow breakeven in FY25 Clinuvel Pharmaceutical H1 FY24 results below consen...

ASX health sector falls broader market with some key names ailing in reporting season CSL Phase III trial fails to meet primary efficacy endpoint but delivers solid H1 FY24 results Neuren Pharmaceuticals falls 13% on Friday after short sel...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

ASX small-cap shares can be a great area of the share market to find little-known opportunities that could deliver strong long-term returns in the form of both dividends and capital growth. Big businesses like Commonwealth Bank of Australi...

  US stocks rose Tuesday, boosted by declines in Treasury yields as Wall Street assessed the geopolitical risks from the Israel-Hamas war. The benchmark 10-year Treasury yield fell nearly 13 basis points to about 4.65 per cent, as investors...

Voltaic Strategic Resources to release more than 31 million fully paid ordinary shares Besra Gold to release more than 51 million CDIs in escrow since the company listed Fertility company Monash IVF to release around 500,000 fully paid ord...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

This Tuesday's trading session has been a pretty depressing one for the All Ordinaries Index (ASX: XAO) and most ASX All Ords shares. At present, the All Ords has lost a notable 0.42% and is back under 7,400 points. But there are a few ASX...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

The ASX is set to open higher on Tuesday It was all about Tesla on Wall Street overnight, as the stock jumps 10pc Morgan Stanley says healthcare stocks are undervalued   Australian shares are set to open higher on Tuesday after a rally on...

  Stocks sold off Wednesday, continuing the sluggish start to September, as concerns mounted that the Federal Reserve may not be done hiking interest rates. The Dow Jones Industrial Average sank 198.78 points, or 0.57 per cent, to end at 34...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

ASX health sector falls in mixed week of FY23 results as reporting season continues Monash IVF reports solid FY23 result and forecasts higher IVF cycles going forward Ramsay healthcare plunges on disappointing FY23 result and cut in final...

Monash IVF's (ASX:MVF) FY23 was in line with guidance of underlying NPAT of $25.5m (up 14.%).

Today, Wednesday the 23rd of August, we are happy to buy BHP Group (ASX:BHP), Data#3 Limited (ASX:DTL), Objective Corporation (ASX:OCL), and Monash IVF (ASX:MVF).

ASX health sector outperforming the broader market but remain flattish for week CSL reports solid FY23 results after record plasma collections and lift in sales  Cochlear FY23 sales revenue increases 19% on pcp to a record $1.956 billion...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Pilbara Minerals to release shares issued under its NED fee sacrifice offer Imricor Medical Systems to release ~75k shares of Class A common stock  Monash IVF Group to release more than 135,000 shares in mid June  Escrow Watch is Stockhea...

Japanese beer giant Kirin becomes substantial shareholder of Blackmores after $1.2 takeover bid State Street Corporation becomes substantial shareholder of Gold Road Resources as gold prices rallies State Street Corporation sells out of Sa...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Have you ever eyed an absolute bargain at a clothing store? Marked down 60% off, too good to miss, right? At least that’s what you thought until it started falling apart after the first few wears. In hindsight, a higher quality product at...

ShareCafeNasdaq declines as indicators point to a weakening US economy                    The Nasdaq Composite fell on Wednesday for a third-straight losing session as investors shifted away from growth stocks amid signs that the US e...

The team at NovaPort Capital knows what they want out of the ASX shares they buy. According to NovaPort senior analyst Tim Binsted, his team looks for 50% upside in share price over the coming three years. And right now there is one stock...

ASX healthcare shares have underperformed the broader market since the pandemic-induced market lows in March 2020. Over the last three years, the S&P/ASX 200 Healthcare index has returned just 5.5% per year compared to the S&P/ASX 2...

ShareCafeUS stocks rocked after Powell’s comments                    Stocks sold off sharply Tuesday after comments from Federal Reserve Chair Jerome Powell suggested that rates may need to go higher for longer, fueling fears of a pot...

ASX health stocks fall 1.2% in the past five days  as macro economic factors weigh on broader markets Monash IVF has reported a solid H1 FY23 result with underlying NPAT of $12.6m, ahead of guidance Pharmaceutical distribution group  EBOS...

There is much macroeconomic and geopolitical manoeuvring that’s distracting investors of ASX shares. But one mustn’t forget the current reporting season has been revealing crucial information about the businesses themselves. Lucky for us,...

Several ASX lithium and resources companies are due to release shares from escrow in March Pilbara Minerals will release 86,528 shares issued to non-executive directors under its NED fee sacrifice offer Newly listed Bubalus Resources will...

Today, Wednesday the 22nd of February, we are happy to buy Coles Group (ASX:COL), SEEK Limited (ASX:SEK), HUB24 Ltd (ASX:HUB) Monash IVF Group (ASX:MVF), and Peter Warren (ASX:PWR).

Plenty of action is in store for us on Tuesday as a number of popular ASX shares hand down their latest results. It should be an insightful day for investors thanks to the breadth of companies set to report. The agenda includes companies...

ASX health stocks finished down 0.3% in the past five days Mixed results for the big health companies during reporting season  Morgans upgrades Nanosonics to an Add rating ahead of its half year results Healthcare and life sciences expert...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

There has been a lot of damage done to a wide range of ASX shares. But, 2023 could be the year that some names surge higher if things go well. ASX shares that are hoping to grow substantially in the coming years could get some traction nex...

Given how many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading brokers have named as...